Potassium voltage-gated channels have been extensively investigated as possible therapeutic targets for CHD (45) and other closely related genes, KCNA5 (46) and KCNQ1 (47), have been previously linked to heart disease. This evidence concerns the gene KCNQ1 and heart disorder.